Impaired endothelium-dependent vasodilation and fibrinolytic dysfunction—generated by hyperglycaemia, insulin resistance, abnormal insulin signalling, chronic inflammation and obesity-derived metabolic derangements—project the foreseeable emergence of cerebrovascular abnormalities [12,13]. The gene discussed is INS; the disease is Obesity.